Herath Mudiyanselage Udari Lakmini Herath , Musun Park , Mei Jing Piao , Kyoung Ah. Kang , Pincha Devage Sameera Madushan Fernando , Herath Mudiyanselage Maheshika Madhuwanthi Senavirathna , Hee-Sun Kim , Sungwook Chae , Young Ree Kim , Jin Won Hyun
{"title":"杨梅素通过抑制内质网应激对pm2.5诱导的细胞凋亡的保护作用","authors":"Herath Mudiyanselage Udari Lakmini Herath , Musun Park , Mei Jing Piao , Kyoung Ah. Kang , Pincha Devage Sameera Madushan Fernando , Herath Mudiyanselage Maheshika Madhuwanthi Senavirathna , Hee-Sun Kim , Sungwook Chae , Young Ree Kim , Jin Won Hyun","doi":"10.1016/j.tiv.2024.106002","DOIUrl":null,"url":null,"abstract":"<div><div>Particulate matter 2.5 (PM<sub>2.5</sub>) exposure is responsible for skin inflammation, aging, and disruption of skin homeostasis. The objective of this investigation was to assess the potential of myricetin in protecting against skin damage caused by PM<sub>2.5</sub>. Human keratinocytes (HaCaT) were pretreated with myricetin and subsequently exposed to PM<sub>2.5</sub>. Cell viability, reactive oxygen species (ROS) generation, oxidized cellular components, mitochondrial damage, cellular apoptosis, and endoplasmic reticulum (ER) stress were assessed. A mitogen-activated protein kinase (MAPK) signaling network was constructed, and the action site of myricetin was explored through docking analysis. PM<sub>2.5</sub> induced oxidative stress, resulting in DNA damage, lipid peroxidation, protein carbonylation, and cellular apoptosis. Myricetin counteracted these effects by reducing the PM<sub>2.5</sub>-induced ROS levels. Additionally, myricetin mitigated the PM<sub>2.5</sub>-induced cytochrome <em>c</em> release into the cytoplasm and caspase activation, thereby ameliorating cellular apoptosis. Myricetin reduced PM<sub>2.5</sub>-induced cytosolic Ca<sup>2+</sup> level and ER-related signaling molecules. Furthermore, myricetin inhibited cellular cytotoxicity by downregulating the MAPK signaling pathway. Docking and network analyses identified 12 major MAPK proteins targeted by myricetin, and these proteins primarily affected the classical MAPK pathway. These findings suggest that myricetin mitigates skin impairments caused by PM<sub>2.5</sub> exposure by reducing ROS, mitochondrial damage, ER stress, and apoptosis via downregulating the MAPK signaling pathway.</div></div>","PeriodicalId":54423,"journal":{"name":"Toxicology in Vitro","volume":"104 ","pages":"Article 106002"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The protective impact of myricetin against PM2.5-induced cellular apoptosis by inhibiting endoplasmic reticulum stress\",\"authors\":\"Herath Mudiyanselage Udari Lakmini Herath , Musun Park , Mei Jing Piao , Kyoung Ah. Kang , Pincha Devage Sameera Madushan Fernando , Herath Mudiyanselage Maheshika Madhuwanthi Senavirathna , Hee-Sun Kim , Sungwook Chae , Young Ree Kim , Jin Won Hyun\",\"doi\":\"10.1016/j.tiv.2024.106002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Particulate matter 2.5 (PM<sub>2.5</sub>) exposure is responsible for skin inflammation, aging, and disruption of skin homeostasis. The objective of this investigation was to assess the potential of myricetin in protecting against skin damage caused by PM<sub>2.5</sub>. Human keratinocytes (HaCaT) were pretreated with myricetin and subsequently exposed to PM<sub>2.5</sub>. Cell viability, reactive oxygen species (ROS) generation, oxidized cellular components, mitochondrial damage, cellular apoptosis, and endoplasmic reticulum (ER) stress were assessed. A mitogen-activated protein kinase (MAPK) signaling network was constructed, and the action site of myricetin was explored through docking analysis. PM<sub>2.5</sub> induced oxidative stress, resulting in DNA damage, lipid peroxidation, protein carbonylation, and cellular apoptosis. Myricetin counteracted these effects by reducing the PM<sub>2.5</sub>-induced ROS levels. Additionally, myricetin mitigated the PM<sub>2.5</sub>-induced cytochrome <em>c</em> release into the cytoplasm and caspase activation, thereby ameliorating cellular apoptosis. Myricetin reduced PM<sub>2.5</sub>-induced cytosolic Ca<sup>2+</sup> level and ER-related signaling molecules. Furthermore, myricetin inhibited cellular cytotoxicity by downregulating the MAPK signaling pathway. Docking and network analyses identified 12 major MAPK proteins targeted by myricetin, and these proteins primarily affected the classical MAPK pathway. These findings suggest that myricetin mitigates skin impairments caused by PM<sub>2.5</sub> exposure by reducing ROS, mitochondrial damage, ER stress, and apoptosis via downregulating the MAPK signaling pathway.</div></div>\",\"PeriodicalId\":54423,\"journal\":{\"name\":\"Toxicology in Vitro\",\"volume\":\"104 \",\"pages\":\"Article 106002\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicology in Vitro\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0887233324002327\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology in Vitro","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887233324002327","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"TOXICOLOGY","Score":null,"Total":0}
The protective impact of myricetin against PM2.5-induced cellular apoptosis by inhibiting endoplasmic reticulum stress
Particulate matter 2.5 (PM2.5) exposure is responsible for skin inflammation, aging, and disruption of skin homeostasis. The objective of this investigation was to assess the potential of myricetin in protecting against skin damage caused by PM2.5. Human keratinocytes (HaCaT) were pretreated with myricetin and subsequently exposed to PM2.5. Cell viability, reactive oxygen species (ROS) generation, oxidized cellular components, mitochondrial damage, cellular apoptosis, and endoplasmic reticulum (ER) stress were assessed. A mitogen-activated protein kinase (MAPK) signaling network was constructed, and the action site of myricetin was explored through docking analysis. PM2.5 induced oxidative stress, resulting in DNA damage, lipid peroxidation, protein carbonylation, and cellular apoptosis. Myricetin counteracted these effects by reducing the PM2.5-induced ROS levels. Additionally, myricetin mitigated the PM2.5-induced cytochrome c release into the cytoplasm and caspase activation, thereby ameliorating cellular apoptosis. Myricetin reduced PM2.5-induced cytosolic Ca2+ level and ER-related signaling molecules. Furthermore, myricetin inhibited cellular cytotoxicity by downregulating the MAPK signaling pathway. Docking and network analyses identified 12 major MAPK proteins targeted by myricetin, and these proteins primarily affected the classical MAPK pathway. These findings suggest that myricetin mitigates skin impairments caused by PM2.5 exposure by reducing ROS, mitochondrial damage, ER stress, and apoptosis via downregulating the MAPK signaling pathway.
期刊介绍:
Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal will focus on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivo findings. The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals). Toxicology in Vitro discourages papers that record reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.